Clinical Trial Update: Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates whether short-term high-dose atorvastatin (80 mg daily) can cause early regression of carotid artery atherosclerotic lesio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Atherosclerosis | Phase 4 | Status: UNKNOWN